These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 18391488)

  • 1. Systematic appraisal using immunohistochemistry of brain pathology in aged and demented subjects.
    Aho L; Parkkinen L; Pirttila T; Alafuzoff I
    Dement Geriatr Cogn Disord; 2008; 25(5):423-32. PubMed ID: 18391488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperphosphorylated tau in the occipital cortex in aged nondemented subjects.
    Pikkarainen M; Kauppinen T; Alafuzoff I
    J Neuropathol Exp Neurol; 2009 Jun; 68(6):653-60. PubMed ID: 19458543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O; Terada S; Ishizu H; Tsuchiya K; Kitamura Y; Ikeda K; Uéda K; Kuroda S
    Acta Neuropathol; 2002 Oct; 104(4):333-41. PubMed ID: 12200618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease.
    Leinonen V; Koivisto AM; Savolainen S; Rummukainen J; Tamminen JN; Tillgren T; Vainikka S; Pyykkö OT; Mölsä J; Fraunberg M; Pirttilä T; Jääskeläinen JE; Soininen H; Rinne J; Alafuzoff I
    Ann Neurol; 2010 Oct; 68(4):446-53. PubMed ID: 20976765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro characterisation of BF227 binding to alpha-synuclein/Lewy bodies.
    Fodero-Tavoletti MT; Mulligan RS; Okamura N; Furumoto S; Rowe CC; Kudo Y; Masters CL; Cappai R; Yanai K; Villemagne VL
    Eur J Pharmacol; 2009 Sep; 617(1-3):54-8. PubMed ID: 19576880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment.
    Attems J; Jellinger KA
    Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease-related plaques in nondemented subjects.
    Elobeid A; Rantakömi S; Soininen H; Alafuzoff I
    Alzheimers Dement; 2014 Sep; 10(5):522-9. PubMed ID: 24742915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of argyrophilic grain disease on the development of dementia and its relationship to concurrent Alzheimer's disease-related pathology.
    Thal DR; Schultz C; Botez G; Del Tredici K; Mrak RE; Griffin WS; Wiestler OD; Braak H; Ghebremedhin E
    Neuropathol Appl Neurobiol; 2005 Jun; 31(3):270-9. PubMed ID: 15885064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
    Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
    Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.
    Ono K; Noguchi-Shinohara M; Yoshita M; Naiki H; Yamada M
    Exp Neurol; 2007 Feb; 203(2):579-83. PubMed ID: 17011551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tau and alpha-synuclein brainstem pathology in Alzheimer disease: relation with extrapyramidal signs.
    Attems J; Quass M; Jellinger KA
    Acta Neuropathol; 2007 Jan; 113(1):53-62. PubMed ID: 17031655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heavy alcohol consumption and neuropathological lesions: a post-mortem human study.
    Aho L; Karkola K; Juusela J; Alafuzoff I
    J Neurosci Res; 2009 Sep; 87(12):2786-92. PubMed ID: 19382227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-protein/A4 deposits are not associated with hyperphosphorylated tau in somatostatin neurons in the hypothalamus of Alzheimer's disease patients.
    van de Nes JA; Konermann S; Nafe R; Swaab DF
    Acta Neuropathol; 2006 Feb; 111(2):126-38. PubMed ID: 16456666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered Proteins in the Aging Brain.
    Elobeid A; Libard S; Leino M; Popova SN; Alafuzoff I
    J Neuropathol Exp Neurol; 2016 Apr; 75(4):316-25. PubMed ID: 26979082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. alpha-Synuclein pathology in the spinal cord autonomic nuclei associates with alpha-synuclein pathology in the brain: a population-based Vantaa 85+ study.
    Oinas M; Paetau A; Myllykangas L; Notkola IL; Kalimo H; Polvikoski T
    Acta Neuropathol; 2010 Jun; 119(6):715-22. PubMed ID: 20037761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.